118 related articles for article (PubMed ID: 2536212)
1. Intratumor application of human leukocyte interferon-alpha in patients with malignant brain tumors.
Jereb B; Petric J; Lamovec J; Skrbec M; Soss E
Am J Clin Oncol; 1989 Feb; 12(1):1-7. PubMed ID: 2536212
[TBL] [Abstract][Full Text] [Related]
2. Addition of IFN-alpha to treatment of malignant brain tumors.
Jereb B; Petric-Grabnar G; Klun B; Lamovec J; Skrbec M; Soos E
Acta Oncol; 1994; 33(6):651-4. PubMed ID: 7946443
[TBL] [Abstract][Full Text] [Related]
3. Malignant astrocytic gliomas in children.
Marchese MJ; Chang CH
Cancer; 1990 Jun; 65(12):2771-8. PubMed ID: 2160318
[TBL] [Abstract][Full Text] [Related]
4. Long-term survival in malignant glioma. Prognostic factors.
Phuphanich S; Ferrall S; Greenberg H
J Fla Med Assoc; 1993 Mar; 80(3):181-4. PubMed ID: 8387566
[TBL] [Abstract][Full Text] [Related]
5. Treatment of malignant brain tumors with focused ultrasound hyperthermia and radiation: results of a phase I trial.
Guthkelch AN; Carter LP; Cassady JR; Hynynen KH; Iacono RP; Johnson PC; Obbens EA; Roemer RB; Seeger JF; Shimm DS
J Neurooncol; 1991 Jun; 10(3):271-84. PubMed ID: 1654406
[TBL] [Abstract][Full Text] [Related]
6. Treatment of advanced CNS malignancies with the recombinant adenovirus H5.010RSVTK: a phase I trial.
Eck SL; Alavi JB; Alavi A; Davis A; Hackney D; Judy K; Mollman J; Phillips PC; Wheeldon EB; Wilson JM
Hum Gene Ther; 1996 Aug; 7(12):1465-82. PubMed ID: 8844206
[TBL] [Abstract][Full Text] [Related]
7. Patterns of failure following treatment for glioblastoma multiforme and anaplastic astrocytoma.
Wallner KE; Galicich JH; Krol G; Arbit E; Malkin MG
Int J Radiat Oncol Biol Phys; 1989 Jun; 16(6):1405-9. PubMed ID: 2542195
[TBL] [Abstract][Full Text] [Related]
8. Effect of lymphokine-activated killer cells with or without radiation therapy against malignant brain tumors.
Nakagawa K; Kamezaki T; Shibata Y; Tsunoda T; Meguro K; Nose T
Neurol Med Chir (Tokyo); 1995 Jan; 35(1):22-7. PubMed ID: 7700478
[TBL] [Abstract][Full Text] [Related]
9. Malignant potential of pleomorphic xanthoastrocytoma.
Vu TM; Liubinas SV; Gonzales M; Drummond KJ
J Clin Neurosci; 2012 Jan; 19(1):12-20. PubMed ID: 22137880
[TBL] [Abstract][Full Text] [Related]
10. Development of anaplastic changes in low-grade astrocytomas of childhood.
Dirks PB; Jay V; Becker LE; Drake JM; Humphreys RP; Hoffman HJ; Rutka JT
Neurosurgery; 1994 Jan; 34(1):68-78. PubMed ID: 8121571
[TBL] [Abstract][Full Text] [Related]
11. Phase II trial of radiotherapy after hyperbaric oxygenation with multiagent chemotherapy (procarbazine, nimustine, and vincristine) for high-grade gliomas: long-term results.
Ogawa K; Ishiuchi S; Inoue O; Yoshii Y; Saito A; Watanabe T; Iraha S; Toita T; Kakinohana Y; Ariga T; Kasuya G; Murayama S
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):732-8. PubMed ID: 21420247
[TBL] [Abstract][Full Text] [Related]
12. [Controlled multimodality treatment of brain stem gliomas].
Kito A; Yoshida J; Kageyama N
No Shinkei Geka; 1987 Jul; 15(7):797-803. PubMed ID: 2823158
[TBL] [Abstract][Full Text] [Related]
13. Recombinant mutant human tumor necrosis factor-alpha (TNF-SAM2) immunotherapy with ranimustine chemotherapy and concurrent radiation therapy for malignant astrocytomas.
Fukushima T; Yamamoto M; Oshiro S; Tsugu H; Hirakawa K; Soma G
Anticancer Res; 2003; 23(6a):4473-81. PubMed ID: 14666736
[TBL] [Abstract][Full Text] [Related]
14. Local administration of interferon for malignant brain tumors.
Nakagawa Y; Hirakawa K; Ueda S; Suzuki K; Fukuma S; Kishida T; Imanishi J; Amagai T
Cancer Treat Rep; 1983 Sep; 67(9):833-5. PubMed ID: 6688376
[TBL] [Abstract][Full Text] [Related]
15. Malignant astrocytic neoplasms: classification, pathologic anatomy, and response to treatment.
Burger PC
Semin Oncol; 1986 Mar; 13(1):16-26. PubMed ID: 3006257
[No Abstract] [Full Text] [Related]
16. Therapy for patients with high grade astrocytoma using intraarterial chemotherapy and radiation therapy.
Madajewicz S; Chowhan N; Tfayli A; Roque C; Meek A; Davis R; Wolf W; Cabahug C; Roche P; Manzione J; Iliya A; Shady M; Hentschel P; Atkins H; Braun A
Cancer; 2000 May; 88(10):2350-6. PubMed ID: 10820358
[TBL] [Abstract][Full Text] [Related]
17. Long-term treatment of malignant gliomas with intramuscularly administered polyinosinic-polycytidylic acid stabilized with polylysine and carboxymethylcellulose: an open pilot study.
Salazar AM; Levy HB; Ondra S; Kende M; Scherokman B; Brown D; Mena H; Martin N; Schwab K; Donovan D; Dougherty D; Pulliam M; Ippolito M; Graves M; Brown H; Ommaya A
Neurosurgery; 1996 Jun; 38(6):1096-103; discussion 1103-4. PubMed ID: 8727138
[TBL] [Abstract][Full Text] [Related]
18. Local immunotherapy (beta-IFN) and systemic chemotherapy in primary glial tumors.
Boiardi A; Silvani A; Milanesi I; Munari L; Broggi G; Botturi M
Ital J Neurol Sci; 1991 Apr; 12(2):163-8. PubMed ID: 1649148
[TBL] [Abstract][Full Text] [Related]
19. Gemistocytic astrocytomas: a reappraisal.
Krouwer HG; Davis RL; Silver P; Prados M
J Neurosurg; 1991 Mar; 74(3):399-406. PubMed ID: 1993905
[TBL] [Abstract][Full Text] [Related]
20. Stereotactic radiosurgery for glial neoplasms of childhood.
Grabb PA; Lunsford LD; Albright AL; Kondziolka D; Flickinger JC
Neurosurgery; 1996 Apr; 38(4):696-701; discussion 701-2. PubMed ID: 8692387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
